Cargando…
Biomarkers and molecular mechanisms of Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease in adults involving non-demyelinating motor disorders. About 90% of ALS cases are sporadic, while 10–12% of cases are due to some genetic reasons. Mutations in superoxide dismutase 1 (SOD1), TAR, c9orf72 (chromosome 9 open read...
Autores principales: | Chakraborty, Ashok, Diwan, Anil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AIMS Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826749/ https://www.ncbi.nlm.nih.gov/pubmed/36660079 http://dx.doi.org/10.3934/Neuroscience.2022023 |
Ejemplares similares
-
Amyotrophic Lateral Sclerosis: Molecular Mechanisms, Biomarkers, and Therapeutic Strategies
por: Yang, Xiaoming, et al.
Publicado: (2021) -
Amyotrophic lateral sclerosis and delayed onset muscle soreness in light of the impaired blink and stretch reflexes – watch out for Piezo2
por: Sonkodi, Balázs, et al.
Publicado: (2022) -
MicroRNAs as Biomarkers in Amyotrophic Lateral Sclerosis
por: Ricci, Claudia, et al.
Publicado: (2018) -
Molecular Motor Proteins and Amyotrophic Lateral Sclerosis
por: Soo, Kai Y, et al.
Publicado: (2011) -
Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)